Rang	Name	Position
1	Mr. Daniel W. Paterson	President, CEO & Director
2	Mr. Daniel Calkins	Chief Financial Officer
3	Dr. Michael Glen Kauffman M.D., Ph.D.	President of Development & Director
4	Dr. Robert A. Weinberg Ph.D.	Co-Founder & Chair of Scientific Advisory Board
5	Dr. Michelle Detwiler M.D., Ph.D.	Co-Founder
6	Ms. Lori Horvat	Executive Vice President of Portfolio Strategy & Operations
7	Dr. Jonathan Pachter Ph.D.	Chief Scientific Officer
8	Ms. Julissa Viana	Vice President of Corporate Communications & Investor Relations
9	Mr. Mark J. Wanda	Senior VP of Legal & Chief Compliance Officer
10	Ms. Cathy Carew	Chief Organizational Effectiveness Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RTW INVESTMENTS, LLC	7,27%	48,18 Mio. USD
2	BlackRock Inc	6,85%	45,39 Mio. USD
3	Deep Track Capital, LP	6,34%	42,06 Mio. USD
4	Armistice Capital, LLC	5,08%	33,64 Mio. USD
5	Nantahala Capital Management, LLC	3,96%	26,26 Mio. USD
6	State Street Corp	3,89%	25,77 Mio. USD
7	Vanguard Capital Management, LLC	3,67%	24,35 Mio. USD
8	Stonepine Capital Management Llc	3,65%	24,20 Mio. USD
9	Foresite Capital Management VI LLC	3,48%	23,05 Mio. USD
10	Morgan Stanley - Brokerage Accounts	2,48%	16,47 Mio. USD
11	Rosalind Advisors, Inc.	2,36%	15,67 Mio. USD
12	Millennium Management LLC	2,30%	15,23 Mio. USD
13	Alyeska Investment Group, L.P.	2,27%	15,02 Mio. USD
14	AIGH Capital Management, LLC	2,13%	14,12 Mio. USD
15	Opaleye Management Inc	1,99%	13,19 Mio. USD
16	Geode Capital Management, LLC	1,90%	12,58 Mio. USD
17	J. Goldman & Co LP	1,86%	12,31 Mio. USD
18	The Goldman Sachs Group Inc	1,64%	10,87 Mio. USD
19	Qube Research & Technologies	1,63%	10,81 Mio. USD
20	NEXTBio Capital Management LP	1,44%	9,58 Mio. USD